Kezdőlap › Áttétes rák › Ohio › Columbus
Áttétes rák klinikai vizsgálatok: Columbus, OH
27 Áttétes rák vizsgálat keres résztvevőket Columbus és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Toborzás folyamatban2. fázis
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- és további 13
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Toborzás folyamatban1. fázis
- Ohio State University Comprehensive Cancer Center, Columbus
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Toborzás folyamatban1. fázis
- ALX Center 10, Columbus
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Toborzás folyamatban2/3. fázis
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Toborzás folyamatban1/2. fázis
- Ohio State University, Columbus
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Toborzás folyamatban3. fázis
- The Mark H Zangmeister Center, Columbus
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Hilliard · 10 mérföldre
SLV-154 Treatment of Advanced Cancers
Toborzás folyamatban1. fázis
- The James Outpatient Care West Center, Columbus
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Toborzás folyamatban3. fázis
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Toborzás folyamatban3. fázis
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Toborzás folyamatban1/2. fázis
- Clinical Study Site, Columbus
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Toborzás folyamatban1. fázis
- Ohio State University Hospital, Columbus
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Toborzás folyamatban3. fázis
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Toborzás folyamatban2. fázis
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
Toborzás folyamatban1. fázis
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Toborzás folyamatban2. fázis
- Ohio State University, Columbus
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Toborzás folyamatban1. fázis
- The Ohio State University (OSU), Columbus
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Toborzás folyamatban1. fázis
- Ohio State University Comprehensive Cancer Center, Columbus
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Toborzás folyamatban3. fázis
- Research Site, Columbus
- Research Site, Hilliard · 10 mérföldre
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Toborzás folyamatban1. fázis
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of LY4175408 in Participants With Advanced Cancer
Toborzás folyamatban1. fázis
- The Ohio State University (OSU) Wexner Medical Center, Columbus
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Toborzás folyamatban1/2. fázis
- OSU Brain & Spine Hospital, Columbus
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Toborzás folyamatban3. fázis
- Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Toborzás folyamatban3. fázis
- Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Toborzás folyamatban2/3. fázis
- The Ohio State University, Columbus
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Toborzás folyamatban1. fázis
- OSU Brain and Spine Hospital, Columbus
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Toborzás folyamatban3. fázis
- The Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Toborzás folyamatbanMegfigyeléses tanulmány
- Massive Bio SYNERGY-AI site, Columbus
Áttétes rák vizsgálatok más városokban
- Houston, TX104 tanulmány
- New York City, NY93 tanulmány
- Nashville, TN70 tanulmány
- Boston, MA63 tanulmány
- Los Angeles, CA57 tanulmány
- St. Louis, MO54 tanulmány
- Arlington, VA53 tanulmány
- Philadelphia, PA46 tanulmány
- Chicago, IL45 tanulmány
- San Antonio, TX44 tanulmány
- Washington, DC43 tanulmány
- Dallas, TX42 tanulmány
Egyéb vizsgálatok: Columbus
- Nem kis sejtes tüdőrák57 tanulmány
- Mellrák40 tanulmány
- Petefészekrák39 tanulmány
- Rák (minden típus)38 tanulmány
- Tüdőrák37 tanulmány
- Akut mieloid leukémia35 tanulmány
- Krónikus limfocitás leukémia28 tanulmány
- Endometriális rák25 tanulmány
- Prosztatarák24 tanulmány
- Multiplex mielóma24 tanulmány
- Kolorektális rák24 tanulmány
- Melanóma21 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 6.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.